NDC 62135-548

LEVETIRACETAM solution

Levetiracetam

LEVETIRACETAM solution is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Chartwell Rx, Llc. The primary component is Levetiracetam.

Product ID62135-548_e29ce1b9-dcc0-6a2c-e053-2995a90a65d2
NDC62135-548
Product TypeHuman Prescription Drug
Proprietary NameLEVETIRACETAM solution
Generic NameLevetiracetam
Dosage FormSolution
Route of AdministrationORAL
Marketing Start Date2009-03-04
Marketing CategoryANDA /
Application NumberANDA090263
Labeler NameChartwell RX, LLC
Substance NameLEVETIRACETAM
Active Ingredient Strength100 mg/mL
Pharm ClassesDecreased Central Nervous System Disorganized Electrical Activity [PE]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 62135-548-47

473 mL in 1 BOTTLE (62135-548-47)
Marketing Start Date2022-06-30
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "LEVETIRACETAM solution" or generic name "Levetiracetam"

NDCBrand NameGeneric Name
0054-0224LevetiracetamLevetiracetam
0121-0799LevetiracetamLEVETIRACETAM
0121-1598LevetiracetamLEVETIRACETAM
0121-2397LevetiracetamLEVETIRACETAM
0121-4799LevetiracetamLEVETIRACETAM
0121-4802LEVETIRACETAMLEVETIRACETAM
0143-9574LevetiracetamLevetiracetam
0143-9673LevetiracetamLevetiracetam
0228-2167LevetiracetamLevetiracetam
0378-5613Levetiracetamlevetiracetam
0378-5615Levetiracetamlevetiracetam
0378-5617Levetiracetamlevetiracetam

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.